Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, K3/705 CSC, Madison, WI, USA.
University of Wisconsin Carbone Cancer Center, Madison, WI, USA.
Leuk Lymphoma. 2023 Jun;64(6):1112-1122. doi: 10.1080/10428194.2023.2202788. Epub 2023 Apr 20.
The highly utilized KC model has a reported lethality rate of about 30%, which has been attributed to pancreas cancer. However, a competing cause of lethality in KC mice is due to the activation of mutant- gene () in the multipotent progenitor cells (MPP), and subsequent development of -mutant T-cell acute lymphoblastic leukemia (T-ALL). Overall, 20% (5/25) of KC mice developed T-ALL by 9 months of age. Transplantation of pooled bone marrow from KC mice into CD45 congenic mice caused T-ALL in 100% of recipient mice, confirming that mutant- expression in the hematologic compartment is driving the development of T-ALL in the KC mouse model. These results are an essential consideration for investigators using this model. Further, the lower penetrance of T-ALL in KC mice (versus existing leukemia models) suggests this model could be considered as an alternative research model to evaluate onset and factors that exacerbate the development of T-ALL.
高使用率的 KC 模型报告的致死率约为 30%,这归因于胰腺癌。然而,KC 小鼠致死的另一个原因是多能祖细胞 (MPP) 中突变基因 () 的激活,以及随后发展为 -突变 T 细胞急性淋巴细胞白血病 (T-ALL)。总体而言,20%(25 只中的 5 只)的 KC 小鼠在 9 个月大时发展为 T-ALL。将 KC 小鼠的骨髓混合液移植到 CD45 同基因小鼠中,导致 100%的受者小鼠发生 T-ALL,这证实了血液系统中突变基因的表达驱动了 KC 小鼠模型中 T-ALL 的发展。这些结果是使用该模型的研究人员必须考虑的因素。此外,与现有的白血病模型相比,KC 小鼠中 T-ALL 的低外显率表明,该模型可以被视为评估 T-ALL 发病和加重因素的替代研究模型。